New cancer drug enters first human trials for Tough-to-Treat tumors
NCT ID NCT05479812
Summary
This is a first-in-human study to test the safety and early effectiveness of a new drug called WTX-124, given alone and in combination with an existing immunotherapy (pembrolizumab). It will enroll about 150 adults with advanced or metastatic solid tumors, such as melanoma or kidney cancer, who have run out of standard treatment options. The main goal is to find a safe dose and see how well patients tolerate the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Emory Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
HonorHealth
Scottsdale, Arizona, 85258, United States
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202, United States
-
Minnesota Oncology Hematology, P.A.
Maple Grove, Minnesota, 55369, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
NEXT Oncology
Houston, Texas, 77054, United States
-
NEXT Oncology
San Antonio, Texas, 78229, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Providence Cancer Institute Franz Clinic
Portland, Oregon, 97213, United States
-
Roswell Park Comprehensive Cancer Care
Buffalo, New York, 14203, United States
-
Texas Oncology - Austin Midtown
Austin, Texas, 78705-1165, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-8852, United States
-
Westchester Medical Center
Hawthorne, New York, 10532, United States
Conditions
Explore the condition pages connected to this study.